T1	Entity 102 123	tumor suppressor gene
T2	KeyEntity 124 127	Apc
T3	Entity 129 155	adenomatous polyposis coli
T4	Entity 176 197	Wnt signaling pathway
T5	Entity 218 229	development
T6	Entity 234 247	tumorigenesis
T7	Entity 291 321	tumor predisposition phenotype
T8	Entity 348 367	embryonic lethality
T9	Entity 326 338	homozygosity
T10	Entity 249 275	Heterozygous knockout mice
T11	KeyEntity 395 398	Apc
T12	Entity 429 442	floxed allele
T13	Entity 489 504	Cre recombinase
T14	Entity 536 546	Keratin 14
T15	Entity 548 551	K14
T16	Entity 582 606	basal cells of epidermis
T17	Entity 628 637	epithelia
T18	Entity 697 714	K14-cre transgene
T19	Entity 834 850	K14-cre–mediated
T20	Entity 851 859	Apc loss
T21	Entity 872 887	aberrant growth
T22	Entity 917 935	squamous epithelia
T23	Entity 896 908	ectodermally
T24	Entity 1015 1034	squamous metaplasia
T25	Entity 1059 1085	epithelial-derived tissues
T26	Entity 1183 1203	thymic abnormalities
T27	Entity 1207 1214	K14-cre
T28	Entity 1216 1231	ApcCKO/CKO mice
T29	KeyEntity 1244 1247	Apc
T30	Entity 1267 1282	embryonic cells
T31	Entity 1294 1315	epithelial cell fates
T32	Entity 1339 1374	epithelial–mesenchymal interactions
T33	Entity 1385 1396	development
R1	other_relation Arg1:T2 Arg2:T3	
#1	AnnotatorNotes R1	is
R2	other_relation Arg1:T2 Arg2:T1	
#2	AnnotatorNotes R2	is
R3	is_part_of Arg1:T2 Arg2:T4	
R4	is_part_of Arg1:T5 Arg2:T4	
R5	is_part_of Arg1:T6 Arg2:T4	
R6	is_part_of Arg1:T7 Arg2:T10	
R7	is_part_of Arg1:T8 Arg2:T9	
R8	interacts_with Arg1:T13 Arg2:T15	
R9	interacts_with Arg1:T16 Arg2:T15	
R10	interacts_with Arg1:T17 Arg2:T15	
T34	Entity 639 654	Mice homozygous
R11	participates_in Arg1:T34 Arg2:T18	
T35	Entity 735 749	stunted growth
R12	participates_in Arg1:T20 Arg2:T21	
R13	participates_in Arg1:T20 Arg2:T22	
R14	is_part_of Arg1:T24 Arg2:T25	
R15	is_part_of Arg1:T26 Arg2:T27	
R16	other_relation Arg1:T30 Arg2:T29	
#3	AnnotatorNotes R16	requires
R17	interacts_with Arg1:T31 Arg2:T32	
